Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share price. Other companies have not been so lucky. The most dramatic positive share moves of the year for the top pharma companies tell compelling stories of ...
We’ve assembled this list of the top 10 US-based companies by revenue, focusing on how they’re seeking to leverage AI and generative AI in their businesses. These use cases span both internal operational and external customer-facing initiatives. AI “ag...
The second-biggest pharmaceutical company out of Switzerland, Novartis has been the face of the pharma industry for about 25 years. The primary manufacturer for the most recognizable drugs on the market pulled in a revenue of over$48 billionin 2020, a 3% increase compared to 2019. ...
The world’s biggest pharmaceutical companies: Top ten by revenue Top pharma companies in 2023. Image courtesy of Dmitry Kalinovsky/Shutterstock. In 2023, established pharma giants such as Johnson & Johnson, Roche, Merck & Co have managed to maintain their positions as the leading drug ...
s perspective, shrinking insurance-side revenue is “like stunting one’s own growth.” But experts also concede that the impacts of vertical consolidation, of the sort CVS and UHG are pursuing, are less well understood, in part because it’s newer, and the companies haven’t been very ...
We estimate drug companies will lose a total of about $50 billion in revenue due to prescription-product patent expirations between 2001 and 2006. (See Exhibit 2.) As we look ahead to 2010, estimated revenue loss for the top 14 pharma companies increases to a total of $85 billion. Those...
Closing businesses, even when it’s the right move, reduces their own tax revenue and creates expensive community turmoil. But they fear opening everything normally would intensify the pandemic. So they flail around, learning by trial and error. It is a messy and ugly process even if everyone...
Biggest Dealmakers of 2010 By Steve Poile, CEO, Wildwood Ventures Ltd This last year has seen significant deal making activity despite the ongoing fallout from the credit crisis. Companies realise that in order to deliver the next generation of therapeutics and therefore revenue streams, there can...
Or the revenue model behind those cute Google Doodles? And don’t the folks on Wall Street and in Silicon Valley work themselves to the bone, too? Well then, they must be doing something useful, right? Maybe not. The typical workday of Goldman Sachs’ CEO may be worlds away from that...
Despite the many challenges facing biotechnology companies, several enterprises have risen to the top of the list. Below, we look at the 10 biggest as measured by12-month trailing(TTM) revenue. This list is limited to publicly traded companies in the U.S. or Canada, either directly or throu...